Article Menu

Export Article

More by Authors Links

Article Data

  • Views 2290
  • Dowloads 145

Case Reports

Open Access

Ectopic pregnancy concomitant with borderline ovarian tumor

  • Ana Carolinne da Silva1
  • Isac Souza Silva Rodrigues1
  • Antônio Carlos Oliveira de Meneses2
  • Eddie Fernando Candido Murta1
  • Rosekeila Simões Nomelini1,*,

1Research Institute of Oncology (IPON)/Department of Gynecology and Obstetrics, Federal University of Triângulo Mineiro, Avenida Getúlio Guaritá, 214. Bairro Abadia. 38025-440. Uberaba – MG Brazil

2Service of Surgical Pathology, Federal University of Triângulo Mineiro, Avenida Getúlio Guaritá, 214. Bairro Abadia. 38025-440. Uberaba – MG Brazil

DOI: 10.31083/j.ejgo.2020.05.5328 Vol.41,Issue 5,October 2020 pp.810-812

Submitted: 01 August 2019 Accepted: 28 October 2019

Published: 15 October 2020

*Corresponding Author(s): Rosekeila Simões Nomelini E-mail: rosekeila@terra.com.br rosekeila.nomelini@pq.cnpq.br

PDF (391.06 kB) View Full-text

Abstract

The most common clinical presentation of ectopic pregnancy is vaginal bleeding in the first trimester and abdominal pain. The existence of a borderline tumor concomitant to ectopic pregnancy has not been described in the literature. The study reported a patient with ectopic pregnancy undergoing surgical treatment, and during the procedure was found an ovarian cyst. Histopathology confirmed the diagnosis of borderline serous cystadenoma. The article demonstrates the need for anatomic-pathological investigation of ovarian cysts, and especially the surgical care in the approach of ectopic pregnancy concomitant with these cysts, since it can occur in women who still desire children, aiming at the maintenance of fertility.


Keywords

Ectopic pregnancy; Borderline serous cystadenoma; Surgical procedure; Ovarian neoplasms.


Cite and Share

Ana Carolinne da Silva,Isac Souza Silva Rodrigues,Antônio Carlos Oliveira de Meneses,Eddie Fernando Candido Murta,Rosekeila Simões Nomelini. Ectopic pregnancy concomitant with borderline ovarian tumor. European Journal of Gynaecological Oncology. 2020. 41(5);810-812.

URL:

https://www.ejgo.net/articles/10.31083/j.ejgo.2020.05.5328

References

[1] Hauptmann S., Friedrich K., Redline R., Avril S.: “Ovarian border-line tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria”. Virchows Arch., 2017, 470, 125-142.

[2] Jurkovic D., Wilkinson H.: “Diagnosis and management of ectopic pregnancy”. BMJ, 2011, 342, d3397-d3397.

[3] Pages-Bouic E., Millet I., Curros-Doyon F., Faget C., Fontaine M., Taourel P.: “Acute pelvic pain in females in septic and aseptic contexts”. Diagn. Interv. Imaging, 2015, 96, 985-995.

[4] Panda S., Darlong L., Singh S., Borah T.: “Case report of a primary ovarian pregnancy in a primigravida”. J. Hum. Reprod. Sci., 2009, 2, 90.

[5] Mergenthal M.C., Senapati S., Zee J., Allen-Taylor L., Whittaker P. G., Takacs P., Sammel M.D., Barnhart K.T.: “Medical Man-agement of Ectopic Pregnancy with Single-Dose and Two-Dose Methotrexate Protocols: Human Chorionic Gonadotropin Trends and Patient Outcomes”. Am. J. Obstet. Gynecol., 2016, 215, 590.

[6] Ohannessian A., Crochet P., Courbiere B., Gnisci A., Agostini A.: “Methotrexate treatment for ectopic pregnancy after assisted reproductive technology: A case-control study”. Gynecol. Obstet. Fertil., 2016, 44, 341-344.

[7] Boots C.E., Hill M.J., Feinberg E.C., Lathi R.B., Fowler S.A., Jungheim E.S.: “Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes”. J. Assist. Reprod. Genet., 2016, 33, 647-656.

[8] du Bois A., Trillsch F., Mahner S., Heitz F., Harter P.: “Management of borderline ovarian tumors”. Ann. Oncol., 2016, 27, i20-i22.

[9] Mangili G., Somigliana E., Giorgione V., Martinelli F., Filippi F., Petrella M.C., et al.: “Fertility preservation in women with border-line ovarian tumours”. Cancer Treat. Rev., 2016, 49, 13-24.


Submission Turnaround Time

Top